As the only national nonprofit advocacy organization focused on hereditary breast and ovarian cancer, FORCE has a strong commitment to promoting research.
Full study details on clinicaltrials.gov
Name of PARP Inhibitor used in study:
Type of study:
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Contact: Chandra P. Belani 717-531-1078 email@example.com
UPMC Cancer Center at Magee-Womens Hospital
Contact: Edward Chu 412-623-5898 firstname.lastname@example.org